88 related articles for article (PubMed ID: 24648472)
1. PD-1 deletion restores susceptibility to experimental autoimmune encephalomyelitis in miR-155-deficient mice.
Zhang J; Braun MY
Int Immunol; 2014 Jul; 26(7):407-15. PubMed ID: 24648472
[TBL] [Abstract][Full Text] [Related]
2. Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.
Oh K; Park HB; Seo MW; Byoun OJ; Lee DS
Clin Immunol; 2012 Nov; 145(2):122-32. PubMed ID: 23001131
[TBL] [Abstract][Full Text] [Related]
3. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
Imler TJ; Petro TM
Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
[TBL] [Abstract][Full Text] [Related]
4. Reduced Treg frequency in LFA-1-deficient mice allows enhanced T effector differentiation and pathology in EAE.
Gültner S; Kuhlmann T; Hesse A; Weber JP; Riemer C; Baier M; Hutloff A
Eur J Immunol; 2010 Dec; 40(12):3403-12. PubMed ID: 21108463
[TBL] [Abstract][Full Text] [Related]
5. PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis.
Carter LL; Leach MW; Azoitei ML; Cui J; Pelker JW; Jussif J; Benoit S; Ireland G; Luxenberg D; Askew GR; Milarski KL; Groves C; Brown T; Carito BA; Percival K; Carreno BM; Collins M; Marusic S
J Neuroimmunol; 2007 Jan; 182(1-2):124-34. PubMed ID: 17182110
[TBL] [Abstract][Full Text] [Related]
6. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
7. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
8. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.
Komiyama Y; Nakae S; Matsuki T; Nambu A; Ishigame H; Kakuta S; Sudo K; Iwakura Y
J Immunol; 2006 Jul; 177(1):566-73. PubMed ID: 16785554
[TBL] [Abstract][Full Text] [Related]
9. Resistance to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis by death receptor 6-deficient mice.
Schmidt CS; Zhao J; Chain J; Hepburn D; Gitter B; Sandusky G; Chintalacharuvu S; Glasebrook A; Na S
J Immunol; 2005 Aug; 175(4):2286-92. PubMed ID: 16081797
[TBL] [Abstract][Full Text] [Related]
10. Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice.
Tan SL; Zhao J; Bi C; Chen XC; Hepburn DL; Wang J; Sedgwick JD; Chintalacharuvu SR; Na S
J Immunol; 2006 Mar; 176(5):2872-9. PubMed ID: 16493044
[TBL] [Abstract][Full Text] [Related]
11. Non-myeloablative transplantation of bone marrow expressing self-antigen establishes peripheral tolerance and completely prevents autoimmunity in mice.
Hosseini H; Oh DY; Chan ST; Chen XT; Nasa Z; Yagita H; Alderuccio F; Toh BH; Chan J
Gene Ther; 2012 Nov; 19(11):1075-84. PubMed ID: 22071968
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
[TBL] [Abstract][Full Text] [Related]
13. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
[TBL] [Abstract][Full Text] [Related]
14. CD43 modulates severity and onset of experimental autoimmune encephalomyelitis.
Ford ML; Onami TM; Sperling AI; Ahmed R; Evavold BD
J Immunol; 2003 Dec; 171(12):6527-33. PubMed ID: 14662853
[TBL] [Abstract][Full Text] [Related]
15. T cell-independent modulation of experimental autoimmune encephalomyelitis in ADAP-deficient mice.
Engelmann S; Togni M; Thielitz A; Reichardt P; Kliche S; Reinhold D; Schraven B; Reinhold A
J Immunol; 2013 Nov; 191(10):4950-9. PubMed ID: 24101551
[TBL] [Abstract][Full Text] [Related]
16. The negative costimulatory molecule PD-1 modulates the balance between immunity and tolerance via miR-21.
Iliopoulos D; Kavousanaki M; Ioannou M; Boumpas D; Verginis P
Eur J Immunol; 2011 Jun; 41(6):1754-63. PubMed ID: 21469086
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-132 suppresses autoimmune encephalomyelitis by inducing cholinergic anti-inflammation: a new Ahr-based exploration.
Hanieh H; Alzahrani A
Eur J Immunol; 2013 Oct; 43(10):2771-82. PubMed ID: 23780851
[TBL] [Abstract][Full Text] [Related]
18. IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice.
Cohen SJ; Cohen IR; Nussbaum G
J Immunol; 2010 Jan; 184(1):212-21. PubMed ID: 19949074
[TBL] [Abstract][Full Text] [Related]
19. Protoporphyrin Treatment Modulates Susceptibility to Experimental Autoimmune Encephalomyelitis in miR-155-Deficient Mice.
Zhang J; Braun MY
PLoS One; 2015; 10(12):e0145237. PubMed ID: 26670809
[TBL] [Abstract][Full Text] [Related]
20. Endogenous estrogens, through estrogen receptor α, constrain autoimmune inflammation in female mice by limiting CD4+ T-cell homing into the CNS.
Lélu K; Delpy L; Robert V; Foulon E; Laffont S; Pelletier L; Engelhardt B; Guéry JC
Eur J Immunol; 2010 Dec; 40(12):3489-98. PubMed ID: 21108469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
